SC Filed 2022-09-20 Event — SEC 0001387131-22-009895 →

GSK PLC → Theravance Biopharma, Inc. TBPH

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 15/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Moderate short days-to-cover (4.5 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

44 transactions

10 buys · 34 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

23 filings by this filer

22 other filings in the data moat

Short Interest · settle 2026-09-15

DTC 4.50

1,686,673 shares short · +4.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $196K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	58,065	—	—
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	6,009	—	—
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	17,000	$20.66	$351K
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	6,000	$20.35	$122K
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	28,000	$10.15	$284K
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	22,044	$10.95	$241K
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	23,576	$9.49	$224K
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	24,258	$9.39	$228K
2026-09-23	PAKIANATHAN DEEPIKA	director	Disposition	13,398	$16.64	$223K
2026-09-23	O'Connor Donal	director	Disposition	74,204	—	—
2026-09-23	O'Connor Donal	director	Disposition	6,009	—	—
2026-09-23	O'Connor Donal	director	Disposition	6,000	$24.43	$147K
2026-09-23	O'Connor Donal	director	Disposition	6,000	$23.85	$143K
2026-09-23	O'Connor Donal	director	Disposition	6,000	$30.14	$181K
2026-09-23	O'Connor Donal	director	Disposition	6,000	$20.35	$122K
2026-09-23	O'Connor Donal	director	Disposition	28,000	$10.15	$284K
2026-09-23	O'Connor Donal	director	Disposition	22,044	$10.95	$241K
2026-09-23	O'Connor Donal	director	Disposition	23,576	$9.49	$224K
2026-09-23	O'Connor Donal	director	Disposition	24,258	$9.39	$228K
2026-09-23	O'Connor Donal	director	Disposition	13,398	$16.64	$223K
2026-09-23	MITCHELL DEAN J	director	Disposition	91,204	—	—
2026-09-23	MITCHELL DEAN J	director	Disposition	6,009	—	—
2026-09-23	MITCHELL DEAN J	director	Disposition	6,000	$24.43	$147K
2026-09-23	MITCHELL DEAN J	director	Disposition	6,000	$23.85	$143K
2026-09-23	MITCHELL DEAN J	director	Disposition	6,000	$30.14	$181K

Showing 25 of 44

Other 13D/G Filings on Theravance Biopharma, Inc.

Filed	Form	Filer	Stake	Shares
2026-09-25	SCHEDULE 13D/A	Weiss Asset Management LP	—	0	view →
2023-08-14	SC	Weiss Asset Management LP	—	—	view →
2022-02-10	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-06-22	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-02-27	SC	GLAXOSMITHKLINE PLC	—	—	view →
2019-04-18	SC	GLAXOSMITHKLINE PLC	—	—	view →

Other Filings by GSK PLC

Filed	Form	Issuer	Stake	Shares
2023-10-10	SC	Haleon plc HLNCF	—	—	view →
2022-11-14	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2022-02-10	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2021-09-16	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2021-09-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-05-25	SC	Innoviva, Inc. INVA	—	—	view →
2021-04-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-04-08	SC	Pandion Therapeutics, Inc.	—	—	view →
2021-02-12	SC	Innoviva, Inc. INVA	—	—	view →
2020-12-07	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-12-07	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2020-10-01	SC	Principia Biopharma Inc.	—	—	view →
2020-06-29	SC	Morphic Holding, Inc.	—	—	view →
2020-06-22	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2020-06-04	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-02-27	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2019-04-18	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2018-07-17	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2018-04-10	SC	Innoviva, Inc. INVA	—	—	view →
2018-02-13	SC	HTG MOLECULAR DIAGNOSTICS, INC	—	—	view →

Showing 20 of 22

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →